Novartis leans toward spinoff of generic drugs unit – Bloomberg NewsBusiness, TherapeuticsNovartis prefers a spinoff of its generic drug unit over a potential sale to private equity firms, Bloomberg News reported on Thursday, citing people familiar with the matter. Read more June 30, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2022/07/ReutersNovartis6-30-2022.jpg 800 1200 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-06-30 12:33:192022-07-01 10:33:46Novartis leans toward spinoff of generic drugs unit – Bloomberg News
